Register entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- Belgium
Authorisation
Registered operations
Analytical testing1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Prothya Biosolutions Belgium | Avenue de Tyras 109, Bruxelles, 1120, Belgium (BEL) | Analytical testing, Finished drug manufacture | 3003208230375250156 |
Compare
Comparable companies in Belgium
- Minakem High Potent1 site · 4 NDC
- argenx BV1 site · 3 NDC
- Henogen1 site · 1 NDC
- Kaneka Eurogentec SA1 site · 1 NDC
- Purna Pharmaceuticals NV1 site · 1 NDC
- UCB, Inc.2 sites · 65 NDC
- Ajinomoto OmniChem N.V.4 sites · 14 NDC
Enquiry
Common questions
- Is Prothya Biosolutions Belgium FDA approved?
- Prothya Biosolutions Belgium holds 1 FDA-registered establishment in Belgium. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Prothya Biosolutions Belgium's drugs manufactured?
- The FDA register lists Bruxelles. Registered operations: analytical testing, finished drug manufacture.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.